US2018264428A1PendingUtilityA1

De novo synthesized gene libraries

Assignee: TWIST BIOSCIENCE CORPPriority: Aug 5, 2013Filed: May 29, 2018Published: Sep 20, 2018
Est. expiryAug 5, 2033(~7 yrs left)· nominal 20-yr term from priority
B01J 2219/00605C12Q 1/6806C40B 40/08C40B 40/06B01J 2219/0059B01J 2219/00378B01J 2219/00587C12N 15/09C12N 15/66B01J 2219/00317B01J 2219/00612C40B 50/18C12N 15/1093B01J 2219/00313B01J 2219/00596C12N 15/74C40B 50/14B01J 2219/00637B01J 2219/00722B01J 2219/00709B01J 2219/00497C40B 50/00B01J 2219/00619B01J 2219/00585C12N 15/1096B01J 2219/00623B01J 19/0046C12N 15/635
76
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

De novo synthesized large libraries of nucleic acids are provided herein with low error rates. Further, devices for the manufacturing of high-quality building blocks, such as oligonucleotides, are described herein. Longer nucleic acids can be synthesized in parallel using microfluidic assemblies. Further, methods herein allow for the fast construction of large libraries of long, high-quality genes. Devices for the manufacturing of large libraries of long and high-quality nucleic acids are further described herein.

Claims

exact text as granted — not AI-modified
1 . A method for synthesizing oligonucleotides, comprising:
 synthesizing a plurality of oligonucleotides at a rate of extending of at least 15 nucleotides per hour, wherein each of the oligonucleotides has a preselected sequence, and wherein the synthesizing comprises extending each oligonucleotide by a single base in an extension reaction.   
     
     
         2 . The method of  claim 1 , wherein the rate of extending is at least 20 nucleotides per hour. 
     
     
         3 . The method of  claim 1 , wherein the rate of extending is at least 25 nucleotides per hour. 
     
     
         4 . The method of  claim 1 , wherein the plurality oligonucleotides are synthesized in parallel. 
     
     
         5 . The method of  claim 1 , wherein at least 20,000 oligonucleotides are synthesized. 
     
     
         6 . The method of  claim 1 , wherein at least 500,000 oligonucleotides are synthesized. 
     
     
         7 . The method of  claim 1 , wherein each of the oligonucleotides is at least 25 bases in length. 
     
     
         8 . The method of  claim 1 , wherein the plurality of oligonucleotides are synthesized on a solid substrate. 
     
     
         9 . The method of  claim 8 , wherein the solid substrate comprises silicon, silicon dioxide or silicon nitride. 
     
     
         10 . The method of  claim 1 , wherein each of the oligonucleotides has a different preselected sequence. 
     
     
         11 . The method of  claim 1 , wherein each of the oligonucleotides comprises 100 to 200 nucleotides in length and is synthesized in less than 5 hours. 
     
     
         12 . A method of synthesizing oligonucleotides, comprising:
 a. providing a solid substrate;   b. depositing droplets at a velocity of 5 m/s to 30 m/s on the substrate, wherein the droplets comprise nucleosides for oligonucleotide synthesis; and   c. synthesizing a plurality of oligonucleotides, wherein each of the oligonucleotides has a preselected sequence.   
     
     
         13 . The method of  claim 12 , wherein the velocity is about 15 m/s, about 20 m/s, or about 25 m/s. 
     
     
         14 . The method of  claim 12 , wherein the plurality of oligonucleotides are synthesized in parallel. 
     
     
         15 . The method of  claim 12 , wherein each droplet has a volume of 1 to 100 picoliters. 
     
     
         16 . The method of  claim 12 , wherein the nucleosides comprise adenine, guanine, thymine, cytosine, uridine group, or a modified nucleotide. 
     
     
         17 . The method of  claim 16 , wherein each of the oligonucleotides is at least 25 bases in length. 
     
     
         18 . The method of  claim 12 , wherein at least 20,000 oligonucleotides are synthesized. 
     
     
         19 . The method of  claim 12 , wherein at least 500,000 oligonucleotides are synthesized. 
     
     
         20 . The method of  claim 12 , wherein the plurality of oligonucleotides is synthesized on a solid substrate. 
     
     
         21 . The method of  claim 20 , wherein the solid substrate comprises silicon, silicon dioxide or silicon nitride. 
     
     
         22 . The method of  claim 12 , wherein each of the oligonucleotides has a different preselected sequence. 
     
     
         23 . A device for oligonucleotide synthesis, comprising:
 a. a solid support;   b. a plurality of locations on a top surface of the solid support, wherein each of the locations has a pitch of 0.5 mm or higher in length; and   c. a plurality of microwells within each of the locations, wherein each of the microwells has a width of up to 500 μm.   
     
     
         24 . The device of  claim 23 , wherein each of the locations has a pitch of 1, 1.1, 1.2, 1.3, 1.4, or 1.5 mm. 
     
     
         25 . The device of  claim 23 , wherein the solid support comprises nylon, nitrocellulose, glass, silica, silicon, polytetraflouroethylene, polypropylene, polystyrene, polycarbonate, gold, platinum, agarose, dextran, polyacrylamides, or polydimethylsiloxane (PDMS). 
     
     
         26 . The device of  claim 23 , wherein the solid support is a plate or a film.

Join the waitlist — get patent alerts

Track US2018264428A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.